A Randomised, Double-Blind, Placebo-Controlled, Cross-Over, Single-Centre Study to Investigate the Acute Lung Deflation Effects of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg Once Daily on Cardiac Biventricular Function and Arterial Stiffness in Adults with COPD
Queen Mary Research Online (Queen Mary University of London)2013
Related Papers
- → Efficacy and safety of fluticasone furoate/vilanterol (50/25 mcg; 100/25 mcg; 200/25 mcg) in Asian patients with chronic obstructive pulmonary disease: a randomized placebo-controlled trial(2015)51 cited
- → Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial(2011)42 cited
- → Efficacy and safety of once-daily fluticasone furoate 50 mcg in adults with persistent asthma: a 12-week randomized trial(2014)20 cited
- → Effect Of Fluticasone Furoate (FF)/Vilanterol (VI) Administered Once Daily On 24h Pulmonary Function In Patients With COPD: A Randomized, Three-Way, Incomplete Block, Cross-Over Study(2012)1 cited
- → The Effect Of Fluticasone Furoate Alone And In Combination With Vilanterol On The Early Asthmatic Response 23 Hours After Dosing In Patients With Mild Persistent Asthma: Results From A 28-Day Randomised, Controlled, Cross-Over Study(2012)